are glp-1 receptor agonists approved for type 1 diabetes fda Evolution of GLP‐1 Treatment GLP-1 Receptor Agonists List: Complete
Description
Naslund et al., 2005
These agents are mainly administered subcutaneously, as they are peptide-based molecules with low bioavailability
doi: 10.1186/s12933-025-02608-9
The first GLP-1 medication, called Byetta (exenatide) , was approved by the FDA in 2005 for type 2 diabetes
Continuous wearable data can show trends but is easily confounded by movement, stress, and measurement artifact
